Biodegradable nanoparticles for protein delivery: Analysis of preparation conditions on particle morphology and protein loading, activity and sustained release properties

Journal of Biomaterials Science, Polymer Edition

Volumn 23, Issue 9, 2012, Pages 1129-1151

  Coleman, Jason ^a   Lowman, Anthony ^a  

^a Drexel University   (United States)

Author keywords

Lyso zyme; Nanoparticles; Poly(lactide co glycolide) (PLGA); Protein delivery; Spinal cord injury; Water oil water (W O W)

Indexed keywords

ACTIVE PROTEINS; BIODEGRADABLE NANOPARTICLE; BOVINE SERUM ALBUMINS; DISPERSITY; DOUBLE EMULSIONS; DRUG-DELIVERY SYSTEMS; ETHYL ACETATES; INVERSE RELATIONSHIP; PARTICLE MORPHOLOGIES; POLY-LACTIDE-CO-GLYCOLIDE; PREPARATION CONDITIONS; PROTEIN ACTIVITY; PROTEIN DELIVERY; PROTEIN DENATURATION; PROTEIN ENCAPSULATION; PROTEIN LOADINGS; SPINAL CORD INJURIES (SCI); SUSTAINED RELEASE; SYNTHESIS CONDITIONS; WEIGHT PERCENT;

ACETONE; COPOLYMERS; DICHLOROMETHANE; EMULSIFICATION; ENCAPSULATION; NANOPARTICLES; PARTICLE SIZE; PROTEINS; SOLUBILITY; SOLVENTS; SUGAR (SUCROSE);

BIOSYNTHESIS;

ACETIC ACID ETHYL ESTER; ACETONE; DICHLOROMETHANE; DRUG ADDITIVE; NANOPARTICLE; ORGANIC COMPOUND; PROTEIN; SOLVENT; ACETIC ACID DERIVATIVE; BOVINE SERUM ALBUMIN; DELAYED RELEASE FORMULATION; LACTIC ACID; LYSOZYME; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; SUCROSE; SUCROSE ACETATE ISOBUTYRATE;

ARTICLE; DRUG DELIVERY SYSTEM; EMULSION; MISCIBILITY; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN STABILITY; SUSTAINED DRUG RELEASE; ANALOGS AND DERIVATIVES; ANIMAL; BOVINE; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; NERVE REGENERATION; PROTEIN DENATURATION; SOLUBILITY; SPINAL CORD INJURIES;

BOVINAE;

ACETATES; ACETONE; ANIMALS; CATTLE; DELAYED-ACTION PREPARATIONS; LACTIC ACID; METHYLENE CHLORIDE; MURAMIDASE; NANOPARTICLES; NERVE REGENERATION; PARTICLE SIZE; POLYGLYCOLIC ACID; PROTEIN DENATURATION; SERUM ALBUMIN, BOVINE; SOLUBILITY; SOLVENTS; SPINAL CORD INJURIES; SUCROSE;

EID: 84867202217     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1163/092050611X576648     Document Type: Article

References (57)

1. P. E. Batchelor and D. W. Howells, J. Clin. Neurosci. 10, 523 (2003).
2. H. Cheng, J. P. Wu and S. F. Tzeng, J. Neurosci. Res. 69, 397 (2002).
3. V. J. Tom and J. D. Houle, Exp. Neurol. 211, 315 (2008).
4. J. Zuo, D. Neubauer, K. Dyess, T. A. Ferguson and D. Muir, Exp. Neurol. 154, 654 (1998).
5. L. W. Yick, W. Wu, K. F. So and D. K. Y. Shum, Neuroreport 11, 1063 (2000).
6. L. D. F. Moon, R. A. Asher, K. E. Rhodes and J. W. Fawcett, Nature Neurosci. 4, 465 (2001).
7. L. Cao, L. Liu, Z.-Y. Chen, L.-M. Wang, J.-L. Ye, H.-Y. Qiu, C.-L. Lu and C. He, Brain 127, 535 (2004).
8. M.-H. Tai, H. Cheng, J.-P. Wu, Y.-L. Liu, P.-R. Lin, J.-S. Kuo, C.-J. Tseng and S.-F. Tzeng, Exp. Neurol. 183, 508 (2003).
9. M. S. Ramer, J. V. Priestley and S. B. McMahon, Nature 403, 312 (2000).
10. K. D. Foust, T. R. Flotte, P. J. Reier and R. J. Mandel, Hum. Gene Ther. 19, 71 (2008).
11. B. S. Bregman, M. McAtee, H. N. Dai and P. L. Kuhn, Exp. Neurol. 148, 475 (1997).
12. Y.-C. Wang, Y.-T. Wu, H.-Y. Huang, H.-I. Lin, L.-W. Lo, S.-F. Tzeng and C.-S. Yang, Biomaterials 29, 4546 (2008).
13. U. Bilati, E. Allémann and E. Doelker, Eur. J. Pharm. Biopharm. 59, 375 (2005).
14. V. R. Sinha and A. Trehan, J. Control. Rel. 90, 261 (2003).
15. A. Sánchez, M. Tobío, L. González, A. Fabra and M. J. Alonso, Eur. J. Pharm. Sci. 18, 221 (2003).
16. R. Gref, P. Quellec, A. Sanchez, P. Calvo, E. Dellacherie and M. J. Alonso, Eur. J. Pharm. Bio-pharm. 51, 111 (2001).
17. M. J. Alonso, R. K. Gupta, C. Min, G. R. Siber and R. Langer, Vaccine 12, 299 (1994).
18. J. L. Cleland and A. J. Jones, Pharm. Res. 13, 1464 (1996).
19. J. L. Cleland, A. Mac, B. Boyd, J. Yang, E. T. Duenas, D. Yeung, D. Brooks, C. Hsu, H. Chu, V. Mukku and A. J. S. Jones, Pharm. Res. 14, 420 (1997).
20. G. Crotts and T. G. Park, J. Microencapsul. 15, 699 (1998).
21. M. Diwan and T. G. Park, J. Control. Rel. 73, 233 (2001).
22. E. Fattal, B. Roques, F. Puisieux, M. J. Blanco-Prieto and P. Couvreur, Adv. Drug Deliv. Rev. 28, 85 (1997).
23. G. Jiang, B. H. Woo, F. Kang, J. Singh and P. P. DeLuca, J. Control. Rel. 79, 137 (2002).
24. W. Lu and T. G. Park, PDA J. Pharm. Sci. Technol. 49, 13 (1995).
25. L. Meinel, O. E. Illi, J. Zapf, M. Malfanti, H. P. Merkle and B. Gander, J. Control. Rel. 70, 193 (2001).
26. G. Mittal, D. K. Sahana, V. Bhardwaj and M. N. V. Ravi Kumar, J. Control Rel. 119, 77 (2007).
27. J. Panyam, M. M. Dali, S. K. Sahoo, W. Ma, S. S. Chakravarthi, G. L. Amidon, R. J. Levy and V. Labhasetwar, J. Control. Rel. 92, 173 (2003).
28. M. J. Blanco-Prieto, E. Leo, F. Delie, A. Gulik, P. Couvreur and E. Fattal, Pharm. Res. 13, 1127 (1996).
29. P. Caroni and M. E. Schwab, J. Cell. Biol. 106, 1281 (1988).
30. S. Freiberg and X. X. Zhu, Int. J. Pharm. 282, 1 (2004).
31. R. A. Jain, C. T. Rhodes, A. M. Railkar, A. W. Malick and N. H. Shah, Eur. J. Pharm. Biopharm. 50, 257 (2000).
32. M. van de Weert, W. E. Hennink and W. Jiskoot, Pharm. Res. 17, 1159 (2000).
33. A. Taluja, Y. S. Youn and Y. H. Bae, J. Mater. Chem. 17, 4002 (2007).
34. H. K. Kim and T. G. Park, J. Control. Rel. 98, 115 (2004).
35. O. L. Johnson, W. Jaworowicz, J. L. Cleland, L. Bailey, M. Charnis, E. Duenas, C. Wu, D. Shepard, S. Magil, T. Last, A. J. Jones and S. D. Putney, Pharm. Res. 14, 730 (1997).
36. H. Sah, J. Pharm. Sci. 88, 1320 (1999).
37. H. Sah, PDA J. Pharm. Sci. Technol. 53, 3 (1999).
38. T. Uchida, K. Shiosaki, Y. Nakada, K. Fukada, Y. Eda, S. Tokiyoshi, N. Nagareya and K. Mat-suyama, Pharm. Res. 15, 1708 (1998).
39. T. D. Dziubla, A. Karim and V. R. Muzykantov, J. Control. Rel. 102, 427 (2005).
40. M. F. Zambaux, F. Bonneaux, R. Gref, E. Dellacherie and C. Vigneron, Int. J. Pharm. 212, 1 (2001).
41. W. Apostoluk and J. Drzymala, J. Colloid Interface Sci. 262, 483 (2003).
42. U. Bilati, E. Allémann and E. Doelker, AAPS PharmSciTech. 6, 594 (2005).
43. H. K. Kim and T. G. Park, Biotechnol. Bioeng. 65, 659 (1999).
44. N. Nihant, C. Schugens, C. Grandfils, R. Jérôme and P. Teyssié, Pharm. Res. 11, 1479 (1994).
45. J. L. Cleland, M. F. Powell and S. J. Shire, Crit. Rev. Ther. Drug Carrier Syst. 10, 307 (1993).
46. J. F. Carpenter, M. J. Pikal, B. S. Chang and T. W. Randolph, Pharm. Res. 14, 969 (1997).
47. M. A. Tracy, K. L. Ward, L. Firouzabadian, Y. Wang, N. Dong, R. Qian and Y. Zhang, Biomaterials 20, 1057 (1999).
48. O. L. Johnson, J. L. Cleland, H. J. Lee, M. Charnis, E. Duenas, W. Jaworowicz, D. Shepard, A. Shahzamani, A. J. S. Jones and S. D. Putney, Nature Med. 2, 795 (1996).
49. L. Chen, R. N. Apte and S. Cohen, J. Control. Rel. 43, 261 (1997).
50. D. K.-L. Xing, D. T. Crane, B. Bolgiano, M. J. Corbel, C. Jones and D. Sesardic, Vaccine 14, 1205 (1996).
51. P. Johansen, Y. Men, R. Audran, G. Corradin, H. P. Merkle and B. Gander, Pharm. Res. 15, 1103 (1998).
52. P. Johansen, H. P. Merkle and B. Gander, Biochim. Biophys. Acta 1425, 425 (1998).
53. E. S. Lee, M. J. Kwon, H. Lee, K. Na and J. J. Kim, Eur. J. Pharm. Sci. 29, 435 (2006).
54. Y. Yeo and K. Park, Arch. Pharm. Res. 27, 1 (2004).
55. D. F. Evans and H. Wennerstrom, Colloidal Domain: Where Physics, Chemistry and Biology Meet, 2nd edn. Wiley-VCH, New York, NY (1999).
56. Y. Tabata and I. Yoshito, J. Biomed. Mater. Res. 22, 837 (1998).
57. J. A. Champion, A. Walker and S. Mitragotri, Pharm. Res. 25, 1815 (2008).